All
Results: 33877-33888 of 48204

Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's disease to the U.S. FDA completed

2024 Kaohsiung Smart City Summit & Expo Showcases Latest Digital and Net-Zero Transformation Technologies
